Neoadjuvant Pembrolizumab Plus Chemo Treats Early TNBC

Rate of event - free survival higher with neoadjuvant pembrolizumab plus chemo versus chemo alone for early triple - negative breast cancer
Source: The Doctors Lounge - Oncology - Category: Cancer & Oncology Tags: Gynecology, Oncology, Pharmacy, Journal, Source Type: news